Death and (hearing) disability as collateral damage for workers {#s0001}
===============================================================

Every day, 6000 women and men die because of occupational fatalities. Of those who survive, 160 million live with disabling injuries or illnesses (International Labour Organisation, [@CIT0019]). Amongst this workforce, hearing loss is the main contributor to disability-adjusted life years for approximately one in five workers (WHO, [@CIT0052]). This highly preventable disability is a global concern. Occupational noise exposure is a major cause of hearing loss (Basner, [@CIT0003]). The general perception is that occupational hearing loss is greater in industrialised (minority world) countries like in Australia, New Zealand, North America and other European countries. However, in less industrialised (majority world) regions, \~21% of workers (vs. \~16% in the minority world) experience disabling hearing loss (Basner et al., [@CIT0004]; Nelson, Nelson, Concha-Barrientos, & Fingerhut, [@CIT0032]).

In, sub-Saharan Africa, the World Bank recently (2016--2017) commissioned a study on occupational health in the mining sector (Osewe & Nkrumah, [@CIT0034]). According to this report, hearing loss accounted for 18% of the burden of injury among ex-mine workers in Lesotho, Mozambique, South Africa and Swaziland. Historically, this is not unusual given how migrant workers across the world were (and continue) to work in 3D (dirty, dangerous and difficult) jobs (Pillay, [@CIT0041]). Osewe and Nkrumah also presented a novel model of worker-centred hearing healthcare across hearing screening, audiological management and aural rehabilitation. Significantly, from an early identification perspective, they stated that during hearing screening (Osewe & Nkrumah, [@CIT0034]):

> If the candidates pass this screening, they would still be eligible for a re-screening every six months to monitor their hearing as part of their being a high-risk group with a history of noise (and/or ototoxic chemical) exposures in the workplace. (p. 173)

This is one of the most significant items in this World Bank's discussion paper. Why? For hearing healthcare in Southern Africa, the World Bank's recommendation represents a shift from relying on a 'noise-only' discourse to explaining occupational hearing loss. Critically, Osewe and Nkrumah have sounded alarm bells about workplace chemicals as contributing to hearing loss too. This positioning of chemical ototoxicity is a fresh challenge for occupational healthcare in less industrialised world regions such as sub-Saharan Africa.

Chemicals with or without noise poison peoples' ears {#s0002}
====================================================

Among occupational healthcare professionals, it is widely known that chemicals affect hearing. It is well established that medications (chemicals) are ototoxic as many illnesses, and diseases in the world are treated using medications with innate ototoxic properties, for example, aspirin (Johnson & Morata, [@CIT0020]). Globally, over 600 categories of medications are identified as potentially ototoxic and include aminoglycoside antibiotics, platinum-based chemotherapeutic agents, loop diuretics, macrolide antibiotics and antimalarials (Ganesan, [@CIT0016]). For example, aminoglycosides (like kanamycin) used to treat tuberculosis (TB) (Khoza-Shangase & Stirk, [@CIT0022]), highly active anti-retroviral therapy (HAART) for human immunodeficiency virus/acquired immunodeficiency syndrome (Khoza-Shangase, 2009) and cisplatin for cancer (Paken, Govender, Pillay & Sewram, [@CIT0035]; Whitehorn et al., [@CIT0050]) are all associated with hearing loss. Notably, these medications also have an impact on the vestibular system, resulting in vertigo or dizziness (Khoza-Shangase, [@CIT0021]). While there is some appreciation of the ototoxic effects of relevant medications (Wium & Gerber, [@CIT0051]), chemicals are rarely recognised as ototoxic agents in South African occupational settings and are not identified as contributing to occupational hearing loss (Manning & Pillay, [@CIT0026]).

Johnson and Morata ([@CIT0020]) reported impact on cochlear and central auditory processing structures owing to ototoxic properties from several solvents, for example, styrene, toluene, xylene, ethylbenzene, trichloroethylene, *n*-hexane, jet fuel, white spirit and other solvent mixtures. Worker-based research studies have focussed mainly on styrene, toluene, lead, mercury, carbon disulphide and carbon monoxide (Johnson & Morata, [@CIT0020]; Nakhooda, Sartorius, & Govender, [@CIT0031]). [Table 1](#T0001){ref-type="table"} shows a review of chemicals (and workplaces) that are potentially ototoxic.

###### 

Lists of chemical exposures and workplaces that are potentially ototoxic.

  Chemical exposures                                                                  Potentially ototoxic workplace
  ----------------------------------------------------------------------------------- ------------------------------------------------------------------
  ***Solvents***                                                                      
  Butanol                                                                             Aircraft maintenance
  Carbon disulphide                                                                   Assay labs
  Ethanol                                                                             Boat building
  Ethyl benzene                                                                       Construction
  *n*-Heptane                                                                         Furniture making
  *n*-Hexane                                                                          Fuelling vehicles and aircraft
  Perchloroethylene                                                                   Fire fighting
  Solvent mixtures and fuels                                                          Painting
  Stoddard solvent (white spirits)                                                    Printing
  Styrene                                                                             Manufacture of metal, fibreglass, leather and petroleum products
  Toluene                                                                             Pesticide spraying
  Trichloroethylene                                                                   Radiator repair
  Xylenes                                                                             Firing of weapons
  ***Metals*** ArsenicLeadManganeseMercuryOrganic tin                                 
  ***Others*** AcrylonitrileCarbon monoxideHydrogen cyanideOrganophosphatesParaquat   

Animal experimental studies (Johnson & Morata, [@CIT0020]) revealed the synergistic effects of noise and solvents (Chen, Chi, Kostyniak, & Henderson, [@CIT0010]), and demonstrated loss of hair cells hypothesised to be caused by the formation of free radicals, namely, reactive oxygen species (Le Prell et al., [@CIT0023]). Johnson and Morata ([@CIT0020]) reported other animal studies where chemicals (metals and pesticides) have damaged the cochlea and central auditory pathways. These animal studies are corroborated by studies of workplace chemicals on the human auditory mechanism (see [Appendix 1](#app001){ref-type="app"}). Ototoxic chemicals may damage the cochlea, vestibular mechanism and/or the auditory neurological pathways, leading to hearing loss, tinnitus and vertigo. The need for evidence regarding noise exposures in combination with workplace chemical exposure has been promoted since the 1990s (Morata & Dunn, [@CIT0028]). For workers exposed to chemicals and noise, this combined exposure has power to, synergistically, potentiate noise-induced hearing loss (Lewkowski et al., [@CIT0024]) even when exposures for each agent alone are measured at acceptable levels (Morata, [@CIT0027]).

In summary, exposure to chemicals in the workplace may be ototoxic. If combined exposures to chemicals and noise occur, then the risk for hearing loss is exacerbated, for example, noise and multiple solvent exposures (Nakhooda et al., [@CIT0031]) or TB medications use/exposure (Khoza-Shangase, [@CIT0021]).However, while this is a known global concern, in South Africa, exposure to chemicals in the workplace is barely/hardly documented.

Why should South African hearing health professionals care? {#s0003}
===========================================================

South Africa's Apartheid government continued British and other European colonial missions to subjugate black South Africans (Pillay & Kathard, [@CIT0043]). Mainly white South African employers and international businesses turned a blind eye to the health and safety of their mainly black South African workers (Gumede, [@CIT0018]). As a South African audiologist having worked under Apartheid and presently working in a post-1994 South Africa, I have observed the continuation of the substandard management of workers' health. Notably, this occurs under a government born from a coalition with worker unions, a constitution that enshrines worker rights replete with worker-oriented policies, protocols and guidelines.

###### 

Included journals with identified data items.

  Journal                                                                                                           Included items   Actual period reviewed
  ----------------------------------------------------------------------------------------------------------------- ---------------- -----------------------------
  African Journal of Disability                                                                                     0                2012 (first volume) to 2019
  African Journal of Primary Health Care & Family Medicine                                                          0                2009 (first volume) to 2019
  South African Medical Journal                                                                                     0                1979--2019
  The South African Journal of Communication Disorders \[Die Suid-Afrikaanse Tydskrif vir Kommunikasieafwykings\]   1                1979--2019
  Health SA Gesondheid                                                                                              0                1996--2019

In Inchanga (KwaZulu-Natal \[KZN\]) in the early 1990s, I worked with communities maimed by the British company, Thor Chemicals. This company is a case in point of how big business and government, enabled by a historicised geopolitical license, value the dollar over death and disability. In the 1970s, they started exporting toxic chemical waste (mainly mercury) to Cato Ridge (KZN) after disallowed to continue operations in England (Carnie, [@CIT0009]). So, from Margate in England to Margate in KZN (and beyond), British toxic waste flowed into the Mgweni River and its tributaries, and found its way into the bodies of workers and local residents. Residents 30--40 km away from the city of Durban/eThekwini washed in these rivers, and drank and irrigated food crops with Thor Chemicals' mercury. Many died, and those residents and workers who survived live as persons with disabilities in contemporary South Africa (Makhaya & Mkhize, [@CIT0025]) with even more worker exposures documented in October 2019 (Carnie, [@CIT0009]).

Corporations with social responsibility on their minds and old and new democracies are bedfellows with the 'unholy trinity': the International Monetary Fund, World Bank and the World Trade Organisation (Peet, [@CIT0036]). Big business makes or uses, stores and/or spills chemicals into water, land and air, resulting in death or disability as the outcome for workers. As workplace chemicals are neurotoxic (some predominantly ototoxic), South African audiologists are obliged to get to know not just what these chemicals are but also where/which occupational settings are likely to be considered 'high-risk'. Such data would inform the management of workers who are vulnerable, key populations at risk of hearing loss, especially when exposed to chemicals with/without noise. Hence, the critical question for this study is: 'what is known about occupational ototoxic chemicals with/without noise exposure in South Africa?'

Aim and objectives {#s0004}
==================

The aim of this study was to identify the coverage of the current body of knowledge of workers' hearing when exposed to ototoxic chemicals with/without noise in literature focussed on South Africa. Topics that have attracted hearing healthcare researchers, and gaps or opportunities for further research will be identified.

Methodology {#s0005}
===========

The selected design is a qualitative, literature mapping study because it is best suited to answer a research question that is about 'what is happening' in a particular subject or field of inquiry. Mapping studies, as a genre of evidence synthesis methods, have been used since the early 1990s by health science researchers. Perryman ([@CIT0037]) reviewed mapping studies relative to other similar methodologies for (1) comprehensiveness, (2) transparency in methodology and (3) rigour. She declared that generic/narrative-type literature reviews are at the one end of a scale, with systematic reviews and meta-analyses on the other end of the scale owing to the nature of their protocols (data retrieval, categorisation, statistical synthesis) and their narrow focus area/topic. Depending on the protocol, mapping studies may -- like scoping reviews -- also categorise literature through content analysis. Dissimilar to other reviews, mapping studies generally do not involve critical content evaluation or statistical synthesis of findings. Indeed, mapping reviews are often misunderstood as scoping reviews and vice versa. However, instead of analysing results, mapping studies identify the relationship between ideas (Perryman, [@CIT0037]). Such studies may occur in one of two formats: firstly, they may be formatted vis-à-vis a visualisation of ideas, not unlike mind or concept maps, for example, see an excellent ototoxicity concept map by Watts ([@CIT0049]). Secondly, and not mutually exclusive, studies are characterised by varying levels of systematic mapping of, for example, where an activity occurred, research funding sources, journal site or mode/medium of presentation. This second format, selected for my study, may include either published, peer-reviewed literature or other media like books, newspapers, policy documents and Internet/electronic data (Cooper, [@CIT0011]).

Data sources {#s0006}
============

Two broad data sets were used: (1) published, peer-reviewed articles -- obtained via two search strategies, detailed below, and (2) grey literature (including print/paper data) tagged by the type or authenticity of the data, see below. Databases used were limited to Google Scholar, PubMed/Medline and ScienceDirect/Scopus for a 40-year period (1979--2019) -- selected for accessibility of electronic and print data.

Sampling {#s0007}
========

Theoretical or operational construct sampling was used because this form of purposive sampling is suited for the selection of data that represent important constructs about the phenomenon of interest (Suri, [@CIT0047]). Operational definitions were developed for the following constructs: chemical ototoxicity with/without noise exposures and occupational hearing loss. A data richness scale was developed (simplified after Ames, Glenton, & Lewin, [@CIT0001]) to rate the amount of data (as per analytical categories, detailed below) in the selected item (e.g. '1' = little/fair data, '5' = large/rich data), and a strategy of sampling for (match of) study scope (cf. inclusion criteria) was used to guide data items selected for mapping.

Search strategy {#s0008}
===============

As the design is a mapping study but with principles adapted from other evidence synthesis methods like scoping and systematic literature reviews, two search strategies were used; the initial search (discussed in detail below) was performed by a research assistant. Firstly, we identified highly ranked journals via the international Scopus[^1^](#FN0001){ref-type="fn"} *SCImago Journal* and Country Rank that were likely to publish articles regarding occupational hearing loss owing to chemical ototoxicity with/without noise, focussed on South Africa. There are inherent limitations to this method, discussed later. However, words (or synonyms) in the journal titles had to be related to 'occupation' and/or 'health', 'hearing', 'disability', 'communication', 'noise', 'pharmaceutical', 'chemical' and/or 'toxicology'. 'African' and/or 'South(ern) Africa' and synonyms were the terms selected to identify and include relevant journals.

Secondly, a search strategy was adapted from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) (Tricco et al., [@CIT0048]). Within this strategy, and given that the Scopus (2018) *SCImago Journal* and Country Rank is limiting by geopolitical intellectual space, I was concerned about a bias/risk of missing unindexed publications from/about South Africa. This then made it necessary to locate articles that were published but not necessarily peer-reviewed, namely, grey literature like items in paper (vs. electronic) versions, for example, unpublished university student dissertations. Across peer-reviewed published and grey literature items, I ensured that all were about South African workers, chemical (with/without) noise exposures and occupational hearing loss. Therefore, keywords searches were completed using medical subject headings (MeSH) or Boolean searches (as per database) for 'chemicals', 'solvents', 'hearing loss', 'ototoxicity', 'audiologist', 'audiology', 'hearing healthcare', 'South Africa', 'Africa', 'industry' and 'occupational health and safety'.

Inclusion and exclusion criteria for articles {#s0009}
=============================================

To develop boundaries, specific inclusion and exclusion criteria were created to facilitate the selection of primary studies for synthesis. The inclusion criteria were that the article content had to focus on: (1) chemical exposures with/without noise in the workplace and that (2) the South African workforce were considered for the time period stipulated above (1979--2019).

Data collection and analysis {#s0010}
============================

A structured data collection schedule was developed and included the following items:

1.  A determination of the number of citations and classification of the literature format types by: booksgovernment documentsInternet sourcemiscellaneous.

2.  Database sorting of format type, cited year (selected as 1979 onwards) and tagged as: 'pre-' if prior to the year range'in-press' for unpublished work in 2019'unknown' for undated items.

3.  When journals changed their titles/names, articles were listed under the most recent title of the journal.

*Development of the data collection tool and process*: A data collection schedule was adapted from the protocols of the Nursing and Allied Health Resources Section (NAHRS) Subcommittee on Mapping the Literature of Nursing and Allied Health (Delwiche, Schloman, & Allen, [@CIT0012]). Nursing and Allied Health Resources Section protocols are premised on Bradford's Law of Scattering (Cooper, [@CIT0011]). This law prescribes reviewing journals over 3 years (not followed here) to establish bibliographic coverage and zoning as to how 'scattered' the topic is across specific journals. This has the potential to influence database producers because it characterises and zones data by accessibility. Therefore, in this study, Bradford's Law of Scattering is applied in principle towards establishing/zoning coverage of the knowledge scatter and not towards quantitative calculations.

Initially, a research assistant and I completed the selection of whole journals by title and specific journal articles were selected by title and abstract. This was a blind review in an attempt to increase inter-rater consistency. We resolved conflicts via discussion and in defence of our application of the inclusion/exclusion criteria, removed duplicates and finalised a single list of journals and articles to review. Notably, where duplicates occurred between published and grey literature, for example, Brits ([@CIT0006]) (an unpublished master's thesis) and Brits, Strauss, Eloff, Becker and Swanepoel ([@CIT0007]) (a published, peer-reviewed item), the latter was selected as superior. The same principle applied within grey literature items like, for example, Edwards ([@CIT0013]) (a conference paper) and Edwards (2012) (a conference poster), the former was selected over the poster version. Once the initial search was completed, I conducted all further article searches (by title and abstracts) in each journal, searched for grey literature and finally conducted an analysis of all selected data items.

*Analysis and interpretation of data:* The emergent-focussed mapping review and synthesis method (Aveyard & Bradbury-Jones, [@CIT0002]) was considered to examine broader epistemological contexts of the knowledge scatter in chemical ototoxicity.

Notably, titles and abstracts were also analysed in this adaption of the PRISMA-ScR as per guidelines by Schultz et al. ([@CIT0045]). Therefore, all selected items were read in full and data were extracted as per the data analysis schedule, adapted from NAHRS (described above). This implies that abstracts constituted full data items and were not up for exclusion but analysed for their content. Numerical analysis of the number of data items by type was computed. The primary focus for this analysis was on capturing patterns and trends in the literature. To do this, data were analysed using Braun and Clarke's ([@CIT0008]) method beginning with: (1) data familiarisation; (2) initial coding; (3) theme identification; (4) theme clustering; (5) theme definition towards a conceptual topography/map; (6) defining/naming themes towards overall patterns; and (7) report of empirical data for analysis. I also performed an ideological critique based on an interrogative framework by Guba and Lincoln ([@CIT0017]), adapted by Pillay (2003) and Pillay and Kathard ([@CIT0043]), and supported with exemplary textual extracts from included articles to demonstrate claims made. No computer software was used in the analysis of the data. Neither were any critical quality appraisals of methodology completed as the purpose was to profile what is happening in the field rather than to draw conclusions from the included studies' findings.

Several methods were used during the data collection and analysis phases to ensure credible, trustworthy data such as establishing the authenticity of data sources via ranked journals. Triangulation of multiple data sources and multiple data collection methods was used to increase trustworthiness of the overall study. In this way, triangulation assisted in a comprehensive understanding of chemicals and hearing loss in the workplace by 'testing' validity through data convergence from different sources (grey, published). The initial blind review for the selection of primary data assisted with data credibility too. Data dependability was checked via a detailed track record of the data collection process. As generalisability is not the goal of this type of qualitative research, transferability was what guided evaluations of the usefulness of data for other contexts or setting conducted via designing reflexive categories of analysis.

Ethical considerations {#s20011}
----------------------
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Results and discussion {#s0012}
======================

In relation to stated aims and objectives, South African workers' exposure to chemicals with/without noise is discussed under the following topics:

1.  current knowledge

2.  focal research topics

3.  knowledge gaps and research opportunities.

Current knowledge {#s0013}
=================

The following journals were identified using the International Scopus (2018) *SCImago Journal* and Country Rank for South Africa only, and by the following subject areas: 'Health Professions', 'Medicine', Multidisciplinary', 'Neuroscience' and 'Pharmacology, Toxicology and Pharmaceutics':

1.  African Journal of Disability

2.  African Journal of Primary Health Care and Family Medicine

3.  South African Medical Journal

4.  The South African Journal of Communication Disorders \[Die Suid-Afrikaanse Tydskrif vir Kommunikasieafwykings\]

5.  Health SA Gesondheid

Journal contents' pages were reviewed (40-year period as per electronic and print media accessibility) for a focus on chemical exposures with/without noise regarding South African workers. Notably, there were no occupational health-related journals ranked by the *SCImago Journal* and Country Rank, in spite of the *Occupational Health Southern Africa* journal being accredited by the Department of Higher Education and Training in South Africa. Across all the journals, only one item per journal was included, which was the same as that identified in the data base searches (Nakhooda et al., [@CIT0031]).

Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guidelines were used to electronically identify the initial data set of 2010 items. Inclusion criteria were applied -- see the PRISMA-ScR flow chart ([Figure 1](#F0001){ref-type="fig"}), adapted from the PRISMA scoping review guidelines for this mapping study.

![Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews flow chart for the mapping review of knowledge about workers' hearing when exposed to ototoxic chemicals with/without noise in literature focussed on South Africa.](SAJCD-67-693-g001){#F0001}

[Table 3](#T0003){ref-type="table"} contains the final included set of 17 items classified by NAHRS categories. Besides six published articles, items included in the data set consist of grey literature items, namely, a professional association (SASLHA) conference programme, a conference paper (full, unpublished) and abstracts of conference presentations. A global discussion paper, published by the World Bank with expert peer input but not peer reviewed, was also included.

###### 

Data items classified by type.

  Type of sources                Total number (17)
  ------------------------------ -------------------
  **Internet sources**           
  Master's thesis                1
  Doctoral/PhD thesis            2
  Published paper                6
  Conference paper (full)        1
  Conference paper (abstract)    3
  Conference poster (abstract)   1
  Abstract (paper)               1
  **Miscellaneous**              
  Conference Programme (print)   1
  Books                          0
  Global discussion paper        1
  Government documents           0

[Table 4](#T0004){ref-type="table"} shows an overview of each item including an evaluation of data richness and sample matching as per inclusion criteria. Notably, three items (Nakhooda, [@CIT0030]; Nakhooda et al., [@CIT0031]; Niranjan [@CIT0033]) are the most suitable for analysis. It may be noted that authors, where possible, were identified as mainly audiologists and/or from community health studies (Niranjan). Most study sites referred to the mining sector, specifically gold mines in Gauteng and environs. Other sites, when stated, included the paint and shoe industries, rubber industries and the informal sector, namely, street market traders that encompassed both urban environmental exposures and other toxins.

###### 

Item classification by type, data richness and sampling match.

  Item                                                         Data type                      Data richness rating   Sampling match
  ------------------------------------------------------------ ------------------------------ ---------------------- ----------------
  Brits et al. ([@CIT0007])                                    Published paper                4                      3
  Edwards and Franz ([@CIT0015])                               Published paper                4                      3
  Edwards ([@CIT0013])                                         Conference paper (full)        4                      5
  Edwards ([@CIT0014])                                         Abstract (paper)               3                      5
  Khoza-Shangase ([@CIT0021])                                  Published paper                5                      4
  Moroe, Khoza-Shangase, Madahana, and Nyandoro ([@CIT0029])   Published paper                5                      3
  Nakhooda ([@CIT0030])                                        Master's thesis (study)        5                      5
  Nakhooda et al. ([@CIT0031])                                 Published paper                5                      5
  Niranjan (2014)                                              Doctoral thesis                5                      5
  Osewe and Nkrumah ([@CIT0034])                               Global discussion paper        4                      4
  Pillay ([@CIT0038])                                          Conference poster (abstract)   3                      4
  Pillay ([@CIT0039])                                          Conference programme (print)   3                      5
  Pillay ([@CIT0040])                                          Conference paper (abstract)    4                      4
  Pillay and Kinnear ([@CIT0044])                              Conference paper (abstract)    4                      4
  Pillay and Booi ([@CIT0042])                                 Conference paper (abstract)    4                      5
  Pillay and Kathard ([@CIT0043])                              Published paper                4                      2
  Strauss ([@CIT0046])                                         D. Phil thesis                 4                      3

Focal research topics {#s0014}
=====================

Most items were focussed on the topic of noise as the point of entry towards understanding chemical ototoxicity in the workplace. All items explicitly refer to combined exposures to chemicals in the workplace. Some make minor references to chemical exposures in their theoretical framework like Edwards ([@CIT0013]). She theorised a '...synergistic effect of chemicals and noise on the inner ear' (p. 2) in her study focussed on multiple risk factors within a synergistic framework, namely, noise, heat and exercise. Significantly, Brits et al. ([@CIT0007]) and Khoza-Shangase ([@CIT0021]) both researched medication-induced ototoxicity (TB) and its ability to potentiate hearing loss by noise in gold mines. Nakhooda ([@CIT0030]) and Nakhooda et al. ([@CIT0031]) are two items emanating from the same study with the latter a systematic review and meta-analysis of the literature. While generated in South Africa and a precursor to the main study (Nakhooda, [@CIT0030]), this literature review decontextualised South African occupational contexts in favour of analysing combined exposures (noise and solvents) as a phenomenon across global literature bases. Niranjan ([@CIT0033]) completed a study in 2014 on combined exposures in rubber factories that produced components for motor, shoe and plumbing industries in the metropolitan area of Durban. Nakhooda's main study overlaps with Niranjan's study as she focussed on workers in the paint and shoe industry. These are the only two South African studies that focussed on noise-chemical exposures and both are based in KZN. My ongoing practice/clinical service project (called *AWEH* -- Advancing Workers' Engagement with Hearing) (see item by Pillay & Kathard, [@CIT0043]) is also based in KZN. This service, alongside the research generated from/about occupational hearing loss, places KZN as the province that promotes audiologists, hearing healthcare of workers and research in occupational ototoxicity. My coauthors (Booi, Kinnear and Kathard) and I have presented conference papers, posters and a publication, with a specific angle on chemical occupational ototoxicity. This work initially focussed on the rubber industry (Pillay, [@CIT0038]), with a current focus on workers in the informal sector, namely, street market traders and the complexity of exposures to car fumes, solvents, related ototoxic medications, smoking, alcohol and music and noise exposures in eThekwini's Warwick Junction markets (see items 11--16).

In summary, research in chemicals and noise exposures in the workplace focus on the mining sector in Gauteng with the interaction of workers on ototoxic medication (for TB and/or HIV) taking precedence. In KZN there appears to be a clearer focus on commerce and industry -- both in the formal and informal sectors. KwaZulu-Natal research and services are developed especially for workers exposed to solvents in combination with noise and other risk factors like ototoxic medication.

Knowledge gaps and research opportunities {#s0015}
=========================================

The most critical gap noted is that there are no governmental policies that link chemical ototoxicity in any South African policy on occupational hearing loss, noise or otherwise. Occupational hearing loss is configured exclusively on the meme that noise exposure is the only toxin. For a more detailed analysis of this bias and/or omission in the law, see Manning and Pillay ([@CIT0026]).

Furthermore, hearing healthcare professional education programmes must consider the informal sector and workers' exposure to a plethora of toxins. The notion of occupational hearing loss owing to ototoxicity must find its way onto the agendas of public and occupational health researchers and practitioners alike. Chemical exposures are only just being recognised as ototoxic in the mining (Osewe & Nkrumah, [@CIT0034]) and other commercial sectors, but this recognition is missing for how workers in the informal sector are managed. While not even noise is managed in the informal occupational sector as yet (Pillay & Kathard, [@CIT0043]), South Africa's recognition of chemical ototoxicity in the occupational sector must include informal workers too as we teach, research and develop policies in occupational hearing healthcare.

Conclusion {#s0016}
==========

In response to the question, 'what is known about occupational ototoxic chemicals with/without noise exposure in South Africa?', this study has mapped the knowledge we are developing in this field in South Africa. However, it does indicate the need for a more systematic evaluation of the nature of studies, their methodological quality and a deeper evaluation of the contribution hearing healthcare researchers make in transforming how employers configure their employers' healthcare.

In a study, entitled 'Hearing Conservation Programmes: For Employers/Workers?', South African formulae for calculating workers' compensation were evaluated for how one accounted for complexities like chemical ototoxic occupational hearing loss (Pillay, [@CIT0038]). What was critiqued almost 20 years ago remains true even today: South African businesses, like mining companies, maintain a strong interest in commercial gain over healthcare. Notions like corporate social responsibility lie uncomfortably when placed next to workers who are econometric instruments in a business. As healthcare professionals, we need to recognise the inherent conflict with hearing conservation activities when considering \>85 dB and solvents; African language speakers and speech audiometry -- or the measurement of occupational hearing impairment versus hearing disability. Our hearing conservation programmes, especially when confounded by chemical exposures, noise and other factors, should always serve the workers' interests and never bow down to the econometric interests of employers.

Wendy Memela (National Research Foundation/Department of Science and Technology research intern at the University of KwaZulu-Natal, Discipline of Speech-Language Pathology) assisted in the initial data collection phase of this study.
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 {#s0022}

The tables below document ototoxic medications by type of effect (hearing loss, tinnitus and vertigo).

###### 

Drugs causing hearing loss as a side effect.

  Drug category                Class of drug                  Subclass of drug                                                                        Examples
  ---------------------------- ------------------------------ --------------------------------------------------------------------------------------- ----------------------------------------------
  Anti-infective               Antibiotics                    Aminoglycosides                                                                         Neomycin, gentamicin, amikacin, netilmicin
  \-                           Macrolides                     Erythromycin, azithromycin, clarithromycin                                              
  \-                           Quinolones                     Ofloxacin, ciprofloxacin, levofloxacin                                                  
  \-                           Others                         Tetracyclines, vancomycin, teicioplanin, framycetin, colistin, imipenem with cilastin   
  Antivirals                   \-                             Ganciclovir, zalcitabine, ribavirin + interferon                                        
  Antifungals                  \-                             Amphotericin, Flucytosine                                                               
  Antimalarials                \-                             Chloroquine, mefloquine, quinine                                                        
  Antituberculous              \-                             Capreomycin                                                                             
  Analgesics                   Non-steroidal                  \-                                                                                      Aspirin, indomethacin, ibuprofen, diclofenac
  Anti-inflammatory            \-                             Ketorolac, sulindac, naproxen                                                           
  Anticancer drugs             Cytotoxics                     Platinum compounds                                                                      Cisplatin, carboplatin, oxaloplatin
  \-                           Vinca alkaloids                Vindesine, vinblastine, vincristine                                                     
  \-                           Others                         Bexarotene, taxane                                                                      
  Cardiac and vascular drugs   Diuretics                      Loop diuretics                                                                          Frusemide, bumentanide, torasemide
  \-                           Carbonic anhydrase inhibitor   Acetazolamide                                                                           
  Beta blockers                \-                             Metoprolol, sotalol, practolol, bisopralol                                              
  ACE inhibitor                \-                             Ramipril                                                                                
  Neurologic drugs             Anticonvulsant                 \-                                                                                      Sodium valproate
  Anti-Parkinson's             \-                             Entacapone                                                                              

*Source*: Bisht, M., & Bist, S.S. ([@CIT0005]). Ototoxicity: The hidden menace. *Indian Journal of Otolaryngology, Head and Neck Surgery, 63*(3), 255--259. <https://doi.org/10.1007/s12070-011-0151-8>

###### 

Drugs causing tinnitus as a side effect.

  Drug category                Class of drug                  Subclass of drug                                                                 Examples
  ---------------------------- ------------------------------ -------------------------------------------------------------------------------- ----------------------------------------------
  Anti-infective               Antibiotics                    Aminoglycosides                                                                  Tobramycin, netilmicin, amikacin
  \-                           Macrolides                     Clarithromycin, azithromycin                                                     
  \-                           Quinolones                     Ciprofloxacin, ofloxacin, norfloxacin                                            
  \-                           Others                         Tetracyclines, vancomycin, teicioplanin, cotrimoxazole, cefpodoxime, linezolid   
  Antivirals                   \-                             Ganciclovir, zalcitabine, Amphotericin                                           
  Antifungals                  \-                             Mefloquine, quinine                                                              
  Antimalarials                \-                             Capreomycin                                                                      
  Antituberculous              \-                             \-                                                                               
  Analgesics diclofenac        Non-steroidal                  \-                                                                               Aspirin, indomethacin, ibuprofen, diclofenac
  Anti-inflammatory            \-                             Ketorolac, sulindac, naproxen, celecoxib                                         
  Anticancer drugs             Cytotoxics                     Platinum compounds                                                               Cisplatin, carboplatin
  \-                           Vinca alkaloids                Vindesine                                                                        
  \-                           Others                         Bexarotene, paclitaxel                                                           
  Cardiac and vascular drugs   Diuretics                      Loop diuretics                                                                   Frusemide, torasemide
  \-                           Potassium sparing diuretic     Amiloride                                                                        
  \-                           Carbonic anhydrase inhibitor   Acetazolamide                                                                    
  Beta blockers                \-                             Metoprolol, timolol                                                              
  Alpha blockers               \-                             Prazocin                                                                         
  ACE inhibitor                \-                             Ramipril, Enalapril, trandolapril                                                
  AT-II receptor               \-                             Irbesartan                                                                       
  Antagonist                   \-                             \-                                                                               
  Anti-arrhythmic              \-                             Flecainide, quinidine, adenosine                                                 
  Calcium channel blockers     \-                             Diltiazem, nicardepine                                                           
  Neurologic drugs             Anticonvulsant                 \-                                                                               Carbamazepine, fosphenytoin
  Anti-depressant              Tricyclics                     Imipramine, amitriptyline                                                        
  \-                           SSRI                           Citalopram                                                                       
  Antimigraine                 5HT-1 antagonist               Almotriptan                                                                      
  Hypnotics                    Benzodiazepine                 (on withdrawal)                                                                  
  Others                       Immunosuppressant              \-                                                                               Tacrolimus
  Antirheumatoid               \-                             Hydroxychloroquine                                                               
  Local anaesthetics           \-                             Lignocaine                                                                       
  Hypoglycaemics               \-                             Tolbutamide                                                                      
  Antihistamines               \-                             Chlorpheniramine                                                                 

*Source*: Bisht, M., & Bist, S.S. ([@CIT0005]). Ototoxicity: The hidden menace. *Indian Journal of Otolaryngology, Head and Neck Surgery, 63*(3), 255--259. <https://doi.org/10.1007/s12070-011-0151-8>

###### 

Drugs causing vertigo or dizziness as a side effect.

  Drug category                Class of drug                  Subclass of drug                                                                                                         Examples
  ---------------------------- ------------------------------ ------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------
  Anti-infective               Antibiotics                    Aminoglycosides                                                                                                          Tobramycin, gentamicin, amikacin, netilmicin
  \-                           Macrolides                     Erythromycin, azithromycin, clarithromycin                                                                               
  \-                           Quinolones                     Ofloxacin, ciprofloxacin, levofloxacin, norflox                                                                          
  \-                           Penicillins                    Piperacillin, amoxicillin                                                                                                
  \-                           Cephalosporins                 Cefpodoxime, cefadroxil, ceftazidime, cefixime, cefalexin, cefaclor, cefazolin, ceftriaxone, cephradine                  
  \-                           Others                         Tetracyclines, vancomycin, teicioplanin, metronidazole, tinidazole, clindamycin, cotrimaxazole, linezolid, pentamidine   
  Antivirals                   \-                             Ganciclovir, zalcitabine, acyclovir, zidovudine, amantadine, ritonavir, lopinavir, indinavir                             
  Antifungals                  \-                             Fluconazole, flucytosine, itraconazole, terbinafine, gresiofulvin                                                        
  Antimalarials                \-                             Hydroxychloroquine, mefloquine, lumefantine                                                                              
  Antituberculous              \-                             Isoniazid, rifampicin, capreomycin, cycloserine                                                                          
  Antihelminthics              \-                             Piperazine                                                                                                               
  Analgesics                   Non-steroidal                  \-                                                                                                                       Aspirin, indomethacin, ibuprofen, diclofenac
  Anti-inflammatory            \-                             Ketorolac, sulindac, naproxen, celecoxib, mefenamic acid, aceclofenac, rofecoxib                                         
  Opioids                      \-                             Morphine, codeine, alfentamil, pethidine, tramadol, dextropropoxyphene                                                   
  Anticancer drugs             Cytotoxics                     Platinum compounds                                                                                                       Cisplatin
  \-                           Vinca alkaloids                Vinblastine                                                                                                              
  \-                           Antimetabolites                Capecitabine, methotrexate, cytarabine                                                                                   
  \-                           Others                         Etoposide, hydroxyurea, procarbazine                                                                                     
  Cardiac and vascular drugs   Diuretics                      Loop diuretics                                                                                                           Frusemide, bumentanide, torasemide
  \-                           Thiazides                      Indapamide, metolazone, bendrofluazide                                                                                   
  \-                           Carbonic anhydrase inhibitor   Acetazolamide, dorzolamide                                                                                               
  \-                           Potassium sparing              Amiloride, spironolactone                                                                                                
  Beta blockers                \-                             Metoprolol, timolol, propranolol, atenolol, pindolol, sotalol, labetolol, carvedilol                                     
  Alpha blockers               \-                             Prazocin, terazosin, doxazocin, tamsulosin                                                                               
  ACE inhibitor                \-                             Ramipril, Enalapril, trandolapril, captopril, perindopril, lisinopril                                                    
  AT-II receptor antagonist    \-                             Irbesartan, losartan, candesartan, valsartan                                                                             
  Anti-arrhythmic              \-                             Flecainide, quinidine, adenosine, digoxin, amiodarone, bretylium, disopyramide                                           
  Calcium channel blockers     \-                             Amlodipine, nifedipine, verapamil                                                                                        
  Nitrates                     \-                             Isosorbide mononitrate, glyceryl trinitrate                                                                              
  Neurologic drugs             Anticonvulsant                 \-                                                                                                                       Sodium valproate, carbamazepine, fosphenytoin, gabapentin, tiagabine, lamotrigine, ethosuccimide
  Anti-depressant              Tricyclics                     Imipramine, amitriptyline, amoxapine                                                                                     
  \-                           SSRI                           Citalopram, fluoxetine, sertraline                                                                                       
  \-                           MAO inhibitors                 Moclobemide                                                                                                              
  Antimigraine                 5HT-1 antagonist               Almotriptan, sumatriptan                                                                                                 
  Hypnotics                    Benzodiazepine                 Clonazepam, lorazepam, diazepam, midazolam, alprazolam                                                                   
  \-                           \-                             Zopiclone, zolpidem                                                                                                      
  Anti-Parkinson's             Other hypnotics                Entacapone, selegiline, biperiden, bromocriptine, pramipexole                                                            
  Antipsychotics               \-                             Thioridazine, olanzapine, clozapine, chlorpromazine, haloperidol, serindole                                              
  Drugs for dementia           \-                             Memantine, galantamine, donepezil                                                                                        
  Muscle relaxant              \-                             Dantrolene, baclofen, tizanidine                                                                                         
  Endocrine and metabolic      Hyperglycemics                 \-                                                                                                                       Glipizide, glimepiride, pioglitazone, insulin
  Corticosteroids              \-                             Dexamethasone, fludrocortisone                                                                                           
  Bisphosphonates              \-                             Pamidronate, zoledronate                                                                                                 
  Gastro intestinal drugs      Antiemetics                    \-                                                                                                                       Metoclopramide, ondansetron, nabilone, trifluoperazine, tropisetron
  Antiulcer                    H2 antagonist                  Ranitidine, cimetidine, famotidine                                                                                       
  \-                           Proton pump                    Omeprazole, lasanoprazole, pantaprazole                                                                                  
  \-                           Inhibitors                     Promethazine, cetrizine, cyclizine                                                                                       
  Lipid regulating             \-                             Fenofibrate, simvastatin, colestipol                                                                                     
  Others                       Immunosuppressant              \-                                                                                                                       Tacrolimus, azathioprine, mycophenolate
  Antirheumatoid               \-                             Leflunomide, etanercept, azathioprine                                                                                    
  Anti-gout                    \-                             Allopurinol                                                                                                              
  Local anaesthetics           \-                             Ropivacaine, lignocaine                                                                                                  
  Antihistamines               \-                             Chlorpheniramine, fexofenadine, promethazine, cetrizine, cyclizine                                                       
  Antimuscarinicss             \-                             Atropine, hyoscine, dicyclomine                                                                                          
  Antiasthamatics              \-                             Salbutamol, montelukast, salmeterol                                                                                      

*Source*: Bisht, M., & Bist, S.S. ([@CIT0005]). Ototoxicity: The hidden menace. *Indian Journal of Otolaryngology, Head and Neck Surgery, 63*(3), 255--259. <https://doi.org/10.1007/s12070-011-0151-8>
